LYPD3 and head and neck squamous cell carcinoma: Subsequent evaluation of these candidates’ expression in normal oral keratinocytes and HNSCC cell lines revealed comparatively lower expression levels of LYPD3 in HNSCC cell lines, suggesting its candidacy as a tumor suppressor gene correlating with the oncogenic role of miR-151-5p (Fig. 2b).